← Back to Patent Explorer
US4118349A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the manufacture of polystyrene latex compounds

Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1977-06-30
•
Granted: 1978-10-03
•
Expires: 1997-06-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to a process for the manufacture of protein or peptide polystyrene latex compounds useful as diagnostic agents, in which a protein or peptide is linked by means of an aromatic diazonium compound to a homo- or copolymer of styrene as well as the compounds obtained by said process.

Inventors

  • 👤 Ludwig Bonacker
  • 👤 Josef Stark

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:58
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; C; C08; C08F; C08F8/00; C12; C12N; C12N11/00; C12N11/02; C12N11/08; C12N11/082; C12N11/087; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/947; Y10S436/00; Y10S436/823

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 100 words
In a process for chemically bonding a protein or peptide to a polymeric carrier which is a styrene homopolymer or a copolymer of styrene with less than 50 percent by weight of acrylic acid or methacrylic acid by contacting (1) a homogeneous aqueous latex suspension of said polymeric carrier, (2) said protein or peptide, and (3) an aromatic diazonium compound at a weakly alkaline pH, the improvements which comprise contacting (1), (2) and (3) at a temperature below room temperature and subsequently adding albumin to the mixture to give an albumin concentration between 0.5 and 1.5 percent in the mixture.
Claim 2
Dependent Claim 100 words
In a process for chemically bonding a protein or peptide to a polymeric carrier which is a styrene homopolymer or a copolymer of styrene with less than 50 percent by weight of acrylic acid or methacrylic acid by contacting (1) a homogeneous aqueous latex suspension of said polymeric carrier, (2) said protein or peptide, and (3) an aromatic diazonium compound at a weakly alkaline pH, the improvements which comprise contacting (1), (2) and (3) at a temperature below room temperature and subsequently adding albumin to the mixture to give an albumin concentration between 0.5 and 1.5 percent in the mixture.
Claim 3
Dependent Claim 24 words
A method as in claim 1, wherein said latex and diazonium compound are first combined and said protein or peptide is then combined therewith.
Claim 4
Dependent Claim 24 words
A method as in claim 1, wherein said latex and protein or peptide are first combined and said diazonium compound is then combined therewith.
Claim 5
Dependent Claim 36 words
A method in claim 1, wherein said diazonium compound is a diazotized amine selected from the group consisting of 2-naphthylamine; 7-ethoxy-3,9-diamino-acridine; aniline; substituted anilines; phenylene diamine, benzidine; dianisidine; diamino-diphenylmethane; diamino-diphenyl-sulfone; benzidine sulfonic acids and p-amino-phenylsulfone-ethoxy-sulfonic acids.
Claim 6
Dependent Claim 24 words
A method as in claim 1, wherein said protein or peptide is a plasmaprotein; a proteohormone; or a viral, bacterial, protozoic, or helminthic protein.
Claim 7
Dependent Claim 18 words
A method as in claim 1, wherein said protein or peptide is an IgE-globulin or the corresponding antibody.
Claim 8
Dependent Claim 17 words
A method as in claim 1, wherein said protein or peptide is the antibody corresponding to haptoglobin.
Claim 9
Dependent Claim 17 words
A method as in claim 1, wherein said protein or peptide is the antibody corresponding to α1-antitrypsin.
Claim 10
Dependent Claim 36 words
A method as in claim 1, wherein said protein or peptide is PP 1 ,PP 2 , or PP 3 pregnancy proteins, or the antibody corresponding to PP 1 , PP 2 or PP 3 .
Claim 11
Dependent Claim 17 words
A method as in claim 1, wherein said protein or peptide is the antibody corresponding to transaminase.
Claim 12
Dependent Claim 20 words
A method as in claim 1, wherein said protein or peptide is a rubella virus protein or the corresponding antibody.
Claim 13
Dependent Claim 14 words
A method as in claim 1, wherein said protein or peptide is a staphylolysin.
Claim 14
Dependent Claim 19 words
A method as in claim 1, wherein said protein or peptide is a bilharziasis antigen or the corresponding antibody.
Claim 15
Dependent Claim 18 words
A method as in claim 13, wherein said bilharziasis antigen or the antibody is derived from Schistosoma mansoni.
Claim 16
Dependent Claim 19 words
A method as in claim 1 wherein said protein or peptide is a protein fraction derived from Entameba histolytica.
Claim 17
Dependent Claim 17 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 1.
Claim 18
Dependent Claim 17 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 7.
Claim 19
Dependent Claim 17 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 8.
Claim 20
Dependent Claim 27 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 11, wherein said protein or peptide is a rubella virus protein.
Claim 21
Dependent Claim 17 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 12.
Claim 22
Dependent Claim 26 words
A polymeric carrier having a protein or peptide bonded thereto, prepared by the method of claim 13, wherein said protein or peptide is a bilharziasis antigen.
Claim 23
Dependent Claim 18 words
A polymeric carrier having a protein or a peptide bonded thereto, prepared by the method of claim 15.

References Cited (Backward Citations)

US3088875A Cited
GB993961A Cited
US3313749A Cited
US3234096A Cited
US3236732A Cited
US3442826A Cited
FR1475600A Cited
US3551555A Cited
US3574062A Cited
US3639558A Cited
US3857931A Cited
US3843447A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-10-02 1982-04-03 1982-10-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-10-02 1986-04-03 1986-10-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-10-02 1990-04-03 1990-10-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag